MicroRNA-144-3p inhibits proliferation and induces apoptosis of human salivary adenoid carcinoma cells via targeting of mTOR

Biotechnology Letters

Volumn 38, Issue 3, 2016, Pages 409-416

  Huo, Fangyi ^a   Zhang, Chen ^a   He, Hong ^a   Wang, Yunlong ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Adenoid cystic carcinoma; Apoptosis; MicroRNA 144 3p; MTOR; Proliferation

Indexed keywords

ASSAYS; CELL CULTURE; CELL DEATH; CELLS; CYTOLOGY; MAMMALS; MOLECULAR BIOLOGY; RNA;

ADENOID CYSTIC CARCINOMATA; CELL VIABILITY ASSAYS; LUCIFERASE REPORTER ASSAYS; MAMMALIAN TARGET OF RAPAMYCIN (MTOR); MICRORNAS; MTOR; PROLIFERATION; PROLIFERATION AND APOPTOSIS;

ANTIBIOTICS;

MICRORNA; MIRN144 MICRORNA, HUMAN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIUM CELL; GENE EXPRESSION PROFILING; HUMAN; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; TOR SERINE-THREONINE KINASES;

EID: 84959107263     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-015-2007-x     Document Type: Article

References (17)

1. Bu LL, Deng WW, Huang CF, Liu B, Zhang WF, Sun ZJ (2015) Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma. Am J Cancer Res 5:1751–1761
2. Cao T, Li H, Hu Y, Ma D, Cai X (2014) miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3. Tumour Biol 35:10759–10764
3. Chen X et al (2011) Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Invest Ophthalmol Sci 52:1193–1199
4. Gobin B et al (2014) NVP-BEZ235, a dual PI3 K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate. Cancer Lett 344:291–298
5. Grabinski N, Ewald F, Hofmann BT, Staufer K, Schumacher U, Nashan B, Jucker M (2012) Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Mol Cancer 11:85
6. Guo Y et al (2013) miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J 280:4531–4538
7. He SQ, Gao M, Fu YF, Zhang YN (2015) Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling. Int J Clin Exp Pathol 8:5175–5181
8. Kalimutho M et al (2011) Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer. J Gastroenterol 46:1391–1402
9. Li M, Sun H, Song L, Gao X, Chang W, Qin X (2012) Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma. Oncol Lett 4:1213–1218
10. Li N, Sui J, Liu H, Zhong M, Zhang M, Wang Y, Hao F (2015a) Expression of phosphorylated Akt/mTOR and clinical significance in human ameloblastoma. Int J Clin Exp Med 8:5236–5244
11. Li T, Luo W, Liu K, Lv X, Xi T (2015b) miR-31 promotes proliferation of colon cancer cells by targeting E2F2. Biotechnol Lett 37:523–532
12. Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM, El-Naggar AK (2013) MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS ONE 8:e66778
13. Spiro RH (1997) Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 174:495–498
14. Yan D et al (2012) Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2. PLoS ONE 7:e40967
15. Yu GT et al (2014) Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma. Am J Cancer Res 4:764–775
16. Zhang LY et al (2013) MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 34:454–463
17. Zhao M et al (2014) The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression. Int J Mol Med 34:1565–1572